Combined Therapy and Jones Technique for Upper Trapezius Myofascial Trigger Points

July 4, 2026 updated by: Isabel de Almeida Paz

Clinical Effects of Combined Therapy, Jones Technique, and Their Combination in Women With Upper Trapezius Myofascial Trigger Points: A Four-Arm Randomized Controlled Trial

Myofascial trigger points in the upper trapezius muscle are a common cause of neck pain and may negatively affect pressure pain threshold, upper limb function, sleep quality, and quality of life. This randomized, sham-controlled clinical trial aimed to compare the effects of the Jones Technique, combined therapy (therapeutic ultrasound plus transcutaneous electrical nerve stimulation [TENS]), their combination, and a sham intervention in women with active upper trapezius myofascial trigger points. The primary outcome was pressure pain threshold. Secondary outcomes included pain intensity, upper limb disability, sleep quality, quality of life, physical activity level, and participant satisfaction.

Study Overview

Detailed Description

Myofascial trigger points (MTrPs) in the upper trapezius muscle are frequently associated with neck pain, reduced pressure pain threshold, and impaired upper limb function. Several conservative interventions have been proposed for the treatment of MTrPs; however, evidence comparing manual therapy and combined electrotherapy remains limited.

This single-center, randomized, sham-controlled, parallel-group clinical trial evaluated the effects of the Jones Technique and combined therapy (therapeutic ultrasound plus transcutaneous electrical nerve stimulation [TENS]) in women aged 18 to 40 years presenting with active myofascial trigger points in the upper trapezius muscle.

Participants were randomly allocated (1:1:1:1) into four groups: (1) Jones Technique; (2) combined therapy; (3) combined therapy plus Jones Technique; and (4) sham control. Randomization was performed using block randomization stratified by age. Participants underwent a single treatment session.

Baseline assessments included demographic data, pain intensity measured using the Visual Analog Scale (VAS), pressure pain threshold measured with a pressure algometer, upper limb disability (DASH), sleep quality (Pittsburgh Sleep Quality Index), quality of life (SF-36), and physical activity level (IPAQ). Immediately after the intervention, pain intensity, pressure pain threshold, and participant satisfaction were reassessed.

The primary outcome was pressure pain threshold. Secondary outcomes included pain intensity, upper limb disability, sleep quality, quality of life, physical activity level, and participant satisfaction.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande do Sul
      • São Leopoldo, Rio Grande do Sul, Brazil
        • Physical Therapy Teaching Clinic, Universidade do Vale do Rio dos Sinos (UNISINOS)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female participants aged 18 to 40 years.
  • Presence of active myofascial trigger points in the upper trapezius muscle for no longer than 12 weeks.
  • Neck pain lasting less than 3 months.
  • Pain intensity of at least 3 cm on the 10-cm Visual Analog Scale (VAS).
  • Ability to understand the study procedures and provide written informed consent.

Exclusion Criteria:

  • Presence of a cardiac pacemaker or other contraindications to electrotherapy.
  • Pregnancy.
  • Uncontrolled cardiovascular disease.
  • Psychiatric disorders that could interfere with study participation.
  • Thrombosis or coagulation disorders.
  • History of tumors or neoplasms.
  • Physical therapy or myofascial treatment within the previous 3 weeks.
  • Treatment for myofascial trigger points within the previous 3 months.
  • Current use of analgesic medications.
  • Cervical musculoskeletal disorders (e.g., cervical osteoarthritis or other cervical lesions).
  • History of cervical trauma or surgery.
  • Cervical spondylosis or spondylolisthesis with radiculopathy.
  • Fibromyalgia or other systemic rheumatic diseases.
  • Other musculoskeletal disorders that could interfere with the study outcomes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Jones Technique
Participants received a single session of the Jones Technique for the treatment of active myofascial trigger points in the upper trapezius muscle.
Manual therapy technique applied to active myofascial trigger points of the upper trapezius muscle. Participants were positioned in prone lying, and sustained pressure with positional release was applied to each trigger point for 90 seconds. Five trigger points were treated during a single treatment session.
Experimental: Combined Therapy
Participants received a single session of combined therapy consisting of therapeutic ultrasound combined with transcutaneous electrical nerve stimulation (TENS) applied to active myofascial trigger points in the upper trapezius muscle.
Combined therapy consisting of pulsed therapeutic ultrasound (1 MHz, 20% duty cycle, 1.0 W/cm²) delivered simultaneously with transcutaneous electrical nerve stimulation (TENS; biphasic asymmetric waveform, 200 μs pulse duration, 100 Hz). Treatment was applied to five active upper trapezius myofascial trigger points during a single 10-minute session.
Experimental: Combined Therapy + Jones Technique
Participants received the Jones Technique followed immediately by combined therapy (therapeutic ultrasound plus transcutaneous electrical nerve stimulation [TENS]) during a single treatment session.
Participants received the Jones Technique followed immediately by combined therapy (therapeutic ultrasound plus transcutaneous electrical nerve stimulation [TENS]) during a single treatment session.
Sham Comparator: Sham Control
Participants underwent all study assessments and received sham treatment consisting of inactive combined therapy (device turned off) and a simulated Jones Technique without therapeutic pressure.
Participants underwent sham treatment consisting of inactive combined therapy with the device turned off and a simulated Jones Technique performed without therapeutic pressure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure Pain Threshold (PPT)
Time Frame: Baseline and immediately after the intervention (single treatment session)
Pressure pain threshold measured with a pressure algometer at five active myofascial trigger points in the upper trapezius muscle. Three measurements were obtained at each assessment
Baseline and immediately after the intervention (single treatment session)
Pain Intensity
Time Frame: Baseline and immediately after the intervention
Pain intensity measured using a 10-cm Visual Analog Scale (VAS).
Baseline and immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper Limb Disability
Time Frame: Baseline
Upper limb disability assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.
Baseline
Sleep Quality
Time Frame: Baseline
Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI).
Baseline
Quality of life
Time Frame: Baseline
Quality of life assessed using the 36-Item Short Form Health Survey (SF-36).
Baseline
Physical Activity Level
Time Frame: Baseline
Physical activity level assessed using the International Physical Activity Questionnaire (IPAQ).
Baseline
Participant Satisfaction
Time Frame: Immediately after the intervention
Participant satisfaction assessed immediately after treatment using a Likert scale.
Immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2024

Primary Completion (Actual)

October 20, 2024

Study Completion (Actual)

December 20, 2024

Study Registration Dates

First Submitted

July 4, 2026

First Submitted That Met QC Criteria

July 4, 2026

First Posted (Actual)

July 10, 2026

Study Record Updates

Last Update Posted (Actual)

July 10, 2026

Last Update Submitted That Met QC Criteria

July 4, 2026

Last Verified

July 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myofascial Trigger Points

Clinical Trials on Jones Technique

3
Subscribe